Ivabradine Tablets, 5 mg and 7.5 mg have an estimated market size of US $ 102 million for twelve months ending December 2021 according to IQVIA
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes
The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Lupin is committed to providing new affordable treatment options to healthcare providers and patients
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
Subscribe To Our Newsletter & Stay Updated
